Connect with us

Financial News

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.Read More

More in Financial News